Optimizing the Use of BTK Inhibitors in the Treatment of Chronic Lymphocytic Leukemia (CLL): Informed Managed Care Decision Making in an Evolving Landscape

Optimizing the Use of BTK Inhibitors in the Treatment of Chronic Lymphocytic Leukemia (CLL): Informed Managed Care Decision Making in an Evolving Landscape

NA

  • Provider:National Association of Managed Care Physicians
  • Activity Link: https://namcp.org/
  • Start Date: 2023-12-01 06:00:00
  • End Date: 2023-12-01 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • Commercial Support: Source: AstraZ - Amount: 57236.0 - Is Kind Support: False
  • Activity Type: Journal-based CE
  • CME Finder Type: Other
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
  • Provider Ship: Jointly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.